HCRTR2 and major depressive disorder: This finding suggests that DORAs may prove counterproductive in sleep disturbances associated with MDD, as preclinical data show that OX1R blockade in the presence of OX2R antagonism dysregulates rapid eye movement (REM) sleep35.